Metraipolis › archive › dc_8036cd7bb7be

Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer — Europe PMC PMID:41227280

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41227280
DOI: 10.3390/jcm14217885
License (as archived): solo-consultazione
Archived: 2026-11-08T18:23:06.231Z
SHA-256 of the archived text: 95a64adb02a4a8af822fc435c89066fc3d0c7610a40edc7476fb6bbd13762646
Stable URL of this page: https://metraipolis.com/documento/dc_8036cd7bb7be

How to cite

Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer — Europe PMC PMID:41227280 — Europe PMC (en), https://europepmc.org/article/MED/41227280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8036cd7bb7be (Metraipolis archive dc_8036cd7bb7be, sha256 95a64adb02a4a8af822fc435c89066fc3d0c7610a40edc7476fb6bbd13762646)

BibTeX

@misc{dc8036cd7bb7be,
  title = {Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer — Europe PMC PMID:41227280},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41227280},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8036cd7bb7be; sha256 95a64adb02a4a8af822fc435c89066fc3d0c7610a40edc7476fb6bbd13762646},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41227280. Agents can read the archived copy with the MCP tool read_document.